Now, Markie, you're getting obsessed again - and, as usual, make far too many assumptions with your arrogance.
My mention on this thread was of NETE, on two occasions - once in early 1998 at $ 1.50 - $ 1.75 or so. About 8 months after you touted MIKL, I believe. It has done well, up about 6-8x from early 1998 to now. And up nearly 3x this year. And since I owned at one time > 2% of the company, it has been quite profitable. I still have a position in it - but I've taken out more than $ 1.5 mm in profit this year. And I've gone on record as saying that I think the stock will move into the 20s in 2000, the 30s in 2001 and likely the 40s in 2002. By my old fashioned reckoning, that's pretty good from an average cost of $ 2.50 or so, and even okay from here.
Now, as regards NPSP and ABMD, I think that I put those as investments that I was interested or invested in when I put up my SI profile. I may be wrong, but please show me the posting on SI on Yahoo wherein I advised others to purchase these stocks.
I've known ABMD since 1983, helped to finance it privately, and at one time owned more than 87,000 shares. Virtually my entire position was sold by the fall of 1997 as the stock moved up into the low 20's when Robertson Stephens filed a 2.0 mm share offering. Made a very satisfactory profit on the stock. I had very few shares remaining when you first posted your silly chart several weeks trying to impugn my investment performance. Out of line, pal, on that one - or rather out to lunch.
I have, however, started to nibble at it again, and have around 10,000 shares now - started buying at $ 9.25 two weeks or so. It's around $ 13.50 now. I'll probably buy more on weakness over the next several months. But please do me a favor - don't soil that stock like you've soiled yourself so many times on this thread.
Finally, re NPSP, at one time I had 180,000 shares, some as low as
$ .33 per share (I owned it when it was private). Also sold most of my shares in 1997 and 1998, also at a very nice profit, before your silly chart had even printed. Still own several thousand shares of NPSP, and expect to add to my position later this year or early next year as the Amgen clinical trials for the NPS 567 analog proceed. By the way, if you check the proxy you will find that NPSP's largest shareholders as Biotech Value Fund, Wellington, T. Rowe Price, and Amgen, which together own around 50% of the total shares outstanding. I know - they're lousy investors, too...
Now all you have done, in advance rather than in retrospect, is dump on Valence and tout MIKL on this thread. You've managed to post - in hindsight - of your investment in VISX and some other fine companies - but only in hindsight. Your record on a current basis is VLNC-no, and MIKL-yes. Not so hot to those of us who have followed your rantings for a couple of years.
Markie, my investment style is different than yours, as I've stated.
It works just fine for me, and I don't have to post to you or anyone else just exactly when I add to or lighten up on any of my positions.
So stop embarrassing yourself when you try to play portfolio manager to someone's else stocks - you seem to have a full enough plate with MIKL. |
